RNU1-103P

Across TCGA pan-cancer cohorts, RNU1-103P RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of RNU1-103P’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RNU1-103P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU1-103P is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

COAD, STAD, and BRCA are the cancer types where RNU1-103P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU1-103P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Male	II,III,IV	+0.982	<.001	6	view →
STAD	Male	IV	+0.425	<.001	4	view →
BRCA	All	All	−0.280	.006	4	view →
CHOL	All	All	+1.828	<.001	3	view →
LUAD	All	All	+0.285	.029	3	view →
LIHC	All	All	+0.190	.020	3	view →
LUSC	All	All	+0.337	.021	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

RNU1-103P–COAD

Open the COAD breakdown →